Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & EMBASE  
     Home | Subscribe | Feedback  

LETTER
[Download PDF
 
Year : 2010  |  Volume : 56  |  Issue : 2  |  Page : 168  

Glucoheptonate for diagnosis of brain tumor

V Wiwanitkit 
 Wiwanitkit House, Bangkhae, Bangkok - 10160, Thailand

Correspondence Address:
V Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok - 10160
Thailand




How to cite this article:
Wiwanitkit V. Glucoheptonate for diagnosis of brain tumor.J Postgrad Med 2010;56:168-168


How to cite this URL:
Wiwanitkit V. Glucoheptonate for diagnosis of brain tumor. J Postgrad Med [serial online] 2010 [cited 2020 Apr 1 ];56:168-168
Available from: http://www.jpgmonline.com/text.asp?2010/56/2/168/65275


Full Text

Sir,

I read the publication on glucoheptonate by Jaiswal et al., with great interest. Jaiswal et al. reached the conclusion that "Glucoheptonate has high degree of specificity for neoplastic tissues of brain and may be used as a tracer for SPECT study to differentiate neoplastic intracranial lesions from non-neoplastic ones." [1] Indeed, glucoheptonate is acceptable in brain oncological imaging. Recently, Barai et al., proposed that glucoheptonate contributed to a reliable diagnostic modality to differentiate tumor recurrence from post-radiation gliosis in patients with medulloblastoma. [2] Barai et al., also noted that glucoheptonate is helpful for diagnosis of recurrent brain tumor. [3] However, additional data on the clinical usefulness of glucoheptonate is still required. First, the cost of this advanced approach compared to its utility must be systematically assessed. Second, the ability of glucoheptonate to differentiate between primary and metastatic lesions and among different kinds and grades of malignancies is still to be proven.

References

1Jaiswal S, Barai S; Rajkumar, Gambhir S, Ora M, Mahapatra AK. Evaluation of intracranial space-occupying lesion with Tc99m-glucoheptonate brain single photon emission computed tomography in treatment-naοve patients. J Postgrad Med 2009;55:180-4.
2Barai S, Bandopadhayaya GP, Julka PK, Kale SS, Kumar R, Malhotra A, et al. Evaluation of Tc99m-glucoheptonate for SPECT functional imaging of medulloblastoma. J Clin Neurosci 2005;12:36-8.
3Barai S, Rajkamal, Bandopadhayaya GP, Pant GS, Haloi AK, Malhotra A, et al. Thallium-201 versus Tc99m-glucoheptonate SPECT for evaluation of recurrent brain tumours: a within-subject comparison with pathological correlation. J Clin Neurosci 2005;12:27-31.

 
Wednesday, April 1, 2020
 Site Map | Home | Contact Us | Feedback | Copyright  and disclaimer